Datapoint: CMS Releases 2025 Star Ratings
October
16
CMS on Oct. 10 released its 2025 Medicare Advantage and Part D Star Ratings, revealing a continued decline in the number of plans achieving high ratings. Only 40% of Medicare Advantage prescription drug (MA-PD) contracts earned four stars or higher for the 2025 plan year, though 62% of all MA-PD members are enrolled in these highly rated contracts (those earning four or more Stars). Among major MA insurers, Humana Inc. saw the biggest ratings drop, as its largest MA contract earned just 3.5 Stars for 2025. Its percentage of members enrolled in highly rated plans plummeted from 94% to 25%, representing 1.55 million members out of 6.07 million.
Source: AIS’s Directory of Health Plans
© 2024 MMIT
Meet Our Reporters
-
Jill Drachenberg Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jill Drachenberg's Profile -
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
